Comments

Jasper Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Jasper Therapeutics (JSPR) operate in?

Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

JSPRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$5.56

-0.02-0.36%

Pre-Market: 6:25 PM EDT

Q4 2024 Earnings were released on Thu Feb 27th, before the market open

Jasper Therapeutics (JSPR) Forecast

News Earnings Jasper Therapeutics (JSPR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Jasper Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:JSPR | Benzinga

Explore Jasper Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for JSPR.

Open	-
Close	-
Volume / Avg.	112.00 / 534.61K
Day Range	- - -
52 Wk Range	4.55 - 31.01
Market Cap	$83.41M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	16.89%
Days to Cover	5.89

Recent News

Crude Oil Down 1%; US Weekly Jobless Claims Decline

Avi Kapoor

Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors

Jasper Therapeutics reports strong briquilimab efficacy in CSU with UAS7 reductions, dose-dependent responses, and Phase 2b plans by late 2025.

Vandana Singh

US Stocks Down; Acuity Brands Posts Weak Revenue

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	112.00 / 534.61K
Day Range	- - -
52 Wk Range	4.55 - 31.01
Market Cap	$83.41M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	16.89%
Days to Cover	5.89

About Jasper Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures throug...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Jasper Therapeutics (JSPR) stock?

You can purchase shares of Jasper Therapeutics (NASDAQ:JSPR) through any online brokerage.

View our list of the best stock brokerages

Who are Jasper Therapeutics (JSPR) competitors?

Other companies in Jasper Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Anixa Biosciences (NASDAQ:ANIX), Cabaletta Bio (NASDAQ:CABA), Skye Bioscience (NASDAQ:SKYE) and Adverum Biotechnologies (NASDAQ:ADVM).

What is the forecast, or price target, for Jasper Therapeutics (JSPR) stock?

Jasper Therapeutics has a consensus price target of $49.82.

What is the current price for Jasper Therapeutics (JSPR)?

The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $5.56 last updated March 3, 2025 at 6:25 PM EST.

Does Jasper Therapeutics (JSPR) pay a dividend?

There are no upcoming dividends for Jasper Therapeutics.

When is Jasper Therapeutics (NASDAQ:JSPR) reporting earnings?

Jasper Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Jasper Therapeutics (JSPR) going to split?

There is no upcoming split for Jasper Therapeutics.

What sector and industry does Jasper Therapeutics (JSPR) operate in?

Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.